ArticleNature communications2025
Breakthrough photothermal ammonia decomposition via low-barrier Ni-CeO
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Electron-Rich Nickel Enabled by Charge Transfer in Multimetal Nanostructures for Efficient Ammonia-to-Hydrogen Conversion.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Tunable Conversion of Ammonia to Hydrazine or Ammonium Nitrite Induced by Acoustic Cavitation Bubbles.ChemSusChem · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Efficient ammonia decomposition is crucial for hydrogen economy, but inexpensive Ni catalysts require excessively high temperatures due to limited N-N coupling. Here, we overcome this challenge by constructing a photothermal catalyst with closely interfaced, defect-rich CeO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.